本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Spruce Biosciences, Inc.

55.35
+0.18500.34%
成交量:6.87萬
成交額:382.21萬
市值:1.59億
市盈率:-1.44
高:56.27
開:55.99
低:54.63
收:55.17
52周最高:240.00
52周最低:7.26
股本:287.40萬
流通股本:228.65萬
量比:1.20
換手率:3.01%
股息:- -
股息率:- -
每股收益(TTM):-38.4300
每股收益(LYR):-50.8298
淨資產收益率:-105.98%
總資產收益率:-40.03%
市淨率:1.90
市盈率(LYR):-1.09

資料載入中...

2024/01/30

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/08

重要事件披露

Form 8-K - Current report
2023/11/13

重要事件披露

Form 8-K - Current report
2023/11/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/14

重要事件披露

Form 8-K - Current report
2023/08/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/30

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/05/26

重要事件披露

Form 8-K - Current report
2023/05/25

重要事件披露

Form 8-K - Current report
2023/05/15

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/15

重要事件披露

Form 8-K - Current report
2023/04/05

SEC問詢函

CORRESP [Cover] - Correspondence
2023/03/16

重要事件披露

8-K - Current report
2023/03/16

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/16

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2023/02/27

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/23

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/02/21

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals